Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
187 studies found for:    Open Studies | "Fatty Liver"
Show Display Options
Rank Status Study
21 Recruiting Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease
Condition: Nonalcoholic Fatty Liver Disease (NAFLD)
Interventions: Drug: Perindopril;   Drug: Telmisartan;   Drug: Amlodipine
22 Recruiting Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.
Condition: Non-alcoholic Fatty Liver Disease
Intervention: Device: FibroScan® examination.
23 Recruiting Fatty Liver Study in Patients With Type II Diabetes
Conditions: Type II Diabetes;   Nonalcoholic Fatty Liver
Interventions: Drug: DPP4 inhibitor;   Drug: Pioglitazone;   Drug: Lantus insulin
24 Recruiting Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis
Conditions: Non-Alcoholic Fatty Liver Disease;   Nonalcoholic Steatohepatitis
Interventions: Drug: Saroglitazar magnesium 1 mg;   Drug: Saroglitazar magnesium 2 mg;   Drug: Saroglitazar magnesium 4 mg;   Drug: Placebos
25 Recruiting Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease
Conditions: Non-alcoholic Fatty Liver Disease (NAFLD);   Non-alcoholic Steatohepatitis (NASH)
Interventions: Behavioral: Mediterranean lifestyle;   Behavioral: Mediterranean Diet
26 Recruiting Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study
Condition: Non-alcoholic Fatty Liver Disease (NAFLD)
Interventions: Drug: Metformin;   Behavioral: Lifestyle modifications;   Device: Fibroscan device (Echosens)
27 Recruiting Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)
Conditions: Non-alcoholic Fatty Liver Disease (NAFLD);   Non-alcoholic Steatohepatitis (NASH)
Interventions: Drug: AZ compound;   Other: Placebo
28 Recruiting Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Conditions: Insulin Resistance;   Nonalcoholic Fatty Liver Disease
Intervention:
29 Recruiting Fatty Liver Disease Collaborative Research in China
Conditions: Fatty Liver;   Fatty Liver, Alcoholic;   Non-alcoholic Fatty Liver Disease
Intervention:
30 Recruiting Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis
Condition: Liver Steatosis
Interventions: Device: Fibroscan;   Biological: Blood test for biological assessment of liver function;   Device: MRI
31 Recruiting The Influence of Autophagy on Fatty Liver
Conditions: Non-alcoholic Fatty Liver Disease;   Obesity
Intervention:
32 Recruiting Metabolic Syndrome and Non-alcoholic Fatty Liver During Pregnancy
Conditions: Fatty Liver;   Gestational Diabetes
Intervention: Other: Liver ultrasound
33 Recruiting Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Study
Condition: Nonalcoholic Fatty Liver Disease
Intervention: Drug: Fecal Microbiota Transplantation
34 Recruiting SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Drug: Metformin;   Drug: SGLT2 inhibitor
35 Recruiting Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis
Condition: Non-alcoholic Steatohepatitis
Interventions: Drug: Atorvastatin;   Drug: L-Carnitine;   Drug: Placebo
36 Recruiting Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for Diagnosis of Hepatic Steatosis
Conditions: Fatty Liver;   Hepatic Steatosis;   Liver Steatosis
Interventions: Device: FibroTouch;   Procedure: Liver Biopsy
37 Recruiting Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant Recipients
Condition: Non-alcoholic Fatty Liver Disease
Intervention:
38 Not yet recruiting A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)
Condition: Non-alcoholic Fatty Liver Disease
Intervention: Biological: Oral Insulin
39 Recruiting Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Drug: Runihol;   Other: Placebo
40 Not yet recruiting Curcumin Supplement in Nonalcoholic Fatty Liver Patients With Type 2 Diabetes
Conditions: Type 2 Diabetes;   Nonalcoholic Fatty Liver
Interventions: Dietary Supplement: curcumin;   Dietary Supplement: placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.